How does SaiyanMed ensure every batch is tested for purity?
SaiyanMed ensures every batch is tested for purity through a mandatory, uncompromising protocol: each production lot is sent to an independent third-party laboratory, Janoshik, for comprehensive HPLC and mass spectrometry analysis, and the resulting Certificates of Analysis (CoAs) are made openly verifiable for every researcher. This isn’t a random sampling or a quarterly check—it’s a batch-by-batch requirement baked into the company’s operational DNA. The process starts at raw material selection, where the founder, Eric, a Materials Science graduate from a leading Chinese university, applies his biomaterials expertise to vet incoming peptide precursors. Only raw materials that pass initial in-house screening for solubility, purity, and structural integrity move forward. Then, during lyophilization—the freeze-drying process that stabilizes the peptide—the production team continuously monitors temperature curves and vacuum pressure to prevent degradation. Once a batch is fully processed, a representative sample is pulled, sealed, and shipped directly to Janoshik, a lab widely recognized in the research community for its stringent testing standards. Janoshik runs high-performance liquid chromatography (HPLC) to quantify purity down to the decimal point and mass spectrometry (MS) to confirm the molecular weight matches the expected sequence. The results are published as a CoA that includes the batch number, the specific peptide tested, the purity percentage, and a chromatogram showing the peak profile. SaiyanMed then uploads these reports to a public database, so you can cross-check the batch number on your vial against the official result. This eliminates the common industry practice of “pool testing,” where multiple batches are blended into a single sample to hide inconsistencies. The company also maintains a US-based warehouse to minimize transit time and temperature fluctuations, which can degrade peptide quality. If a batch fails to meet the stated purity threshold—typically 98% or higher for most research-grade peptides—it is quarantined and not shipped. This system isn’t just about compliance; it’s about giving researchers a reliable foundation for their work. For a deeper look into their testing philosophy and product lineup, you can explore saiyanmed.
The Independent Lab Mandate: Why Janoshik Is Non-Negotiable
Many peptide suppliers claim third-party testing, but SaiyanMed’s relationship with Janoshik goes beyond a simple invoice. Janoshik operates as a fully independent analytical laboratory based in the Czech Republic, with no financial or ownership ties to SaiyanMed. This separation is critical for unbiased results. The lab uses an Agilent 1260 Infinity II HPLC system equipped with a UV-Vis detector, calibrated against certified reference standards. For each test, they inject a 10 µL sample of the reconstituted peptide into a C18 reverse-phase column, running a gradient of acetonitrile and water with 0.1% trifluoroacetic acid over 30 minutes. The resulting chromatogram shows every peak—the main peptide peak and any impurities, such as truncated sequences, oxidized variants, or residual solvents. Janoshik then calculates purity by integrating the area under the main peak relative to the total area. For mass spectrometry, they use a Q-TOF instrument to confirm the monoisotopic mass within 5 ppm of the theoretical value. This dual-method approach catches both purity issues and mislabeling. For example, if a vial claims to contain BPC-157 but the mass spec shows a different molecular weight, the batch is flagged. SaiyanMed publishes these CoAs with a unique identifier, and you can request a direct link from their support team. The company also retains a portion of each batch in a controlled environment for at least six months, allowing for retesting if a researcher questions the results. This level of transparency is rare in the industry, where many suppliers either skip testing or use in-house labs that lack accreditation. By tying every batch to an independent lab report, SaiyanMed effectively turns its inventory into a verifiable data set.
Raw Material Sourcing: The First Purity Gate
Purity testing doesn’t start at the finished vial—it starts with the raw material suppliers. SaiyanMed sources peptide raw materials from a curated list of manufacturers, primarily in China and India, who meet specific criteria: they must use solid-phase peptide synthesis (SPPS) with Fmoc chemistry, provide their own CoAs, and allow on-site audits. Eric, the founder, personally evaluates these suppliers based on his Materials Science background, focusing on metrics like crude purity after cleavage, the efficiency of the deprotection steps, and the resin loading capacity. Raw materials are tested for residual solvents (like acetonitrile, methanol, and DCM) using gas chromatography, with acceptable limits set at less than 100 ppm per solvent. Counterion content—typically trifluoroacetate (TFA)—is measured via ion chromatography and must fall within 5-15% by weight, depending on the peptide. Any raw material batch that shows TFA levels outside this range is rejected because it can affect solubility and biological activity. The company also screens for heavy metals (lead, arsenic, cadmium, mercury) using ICP-MS, with thresholds aligned to USP <232> standards. For instance, lead must be below 0.5 ppm. These raw material tests are documented and cross-referenced with the final product CoAs. If a raw material passes, it moves to the lyophilization facility, which is a joint manufacturing partnership that SaiyanMed co-manages. This facility operates under GMP-like conditions, with HEPA-filtered air, temperature-controlled rooms (18-22°C), and relative humidity below 40%. The equipment is cleaned between runs using a validated CIP (clean-in-place) protocol that includes a 1% NaOH wash followed by a water rinse to pH neutral. Every step is logged in a batch record that includes operator initials, timestamps, and equipment IDs. This traceability ensures that if a purity issue arises, SaiyanMed can pinpoint whether it originated from the raw material, the synthesis, or the lyophilization step.
Lyophilization Process: Freeze-Drying Without Degradation
The lyophilization process is where many peptides lose purity due to improper freezing or drying rates. SaiyanMed uses a controlled cycle that varies by peptide but follows a general framework. The solution is first frozen to -40°C at a rate of 1°C per minute, ensuring ice crystals form uniformly. Then, primary drying occurs at -20°C under a vacuum of 100 mTorr for 24-48 hours, depending on the peptide’s concentration and vial fill volume. Secondary drying ramps the temperature to 25°C over 6 hours and holds it for another 12 hours to remove bound water. The final residual moisture is measured using Karl Fischer titration and must be below 2% for most peptides. This moisture level is critical because excess water can accelerate hydrolysis and microbial growth. During the process, the freeze-dryer’s pressure and temperature sensors are calibrated monthly, and the data is logged automatically. SaiyanMed also uses a “stoppering under vacuum” technique, where the vial stoppers are partially seated during drying and fully pressed in under vacuum at the end, preventing air and moisture from re-entering. This eliminates the need for backfilling with inert gas, which can introduce contaminants. After lyophilization, the vials are visually inspected for cracks, discoloration, or cake collapse—a sign of improper drying. Any vial that looks off is discarded. The batch is then sampled for Janoshik testing. The company also conducts in-house stability tests on a subset of vials, storing them at 25°C/60% RH and 40°C/75% RH for up to four weeks, then retesting for purity changes. Data from these studies inform the expiration date and storage recommendations printed on the label. For example, a peptide like TB-500 might show less than 1% degradation over 30 days at 25°C, while a more fragile peptide like Melanotan II might require refrigeration. This data is shared with researchers upon request.
Data Transparency: How You Verify the Results
The purity data isn’t locked behind a login or a sales call. SaiyanMed publishes every CoA on its website, organized by batch number. You can take the batch number from your vial label, enter it into the search field, and pull up the corresponding PDF. The PDF includes the peptide name, batch number, date of testing, purity percentage (e.g., 98.7%), the HPLC chromatogram image, the mass spectrometry spectrum, and the signature of the Janoshik analyst. The chromatogram shows the retention time and peak area for the main peak, plus any impurity peaks with their relative percentages. For example, a typical CoA might show a main peak at 12.34 minutes with 99.1% purity, and two minor impurity peaks at 8.45 minutes (0.5%) and 15.22 minutes (0.4%). The mass spectrum confirms the molecular ion, typically showing the [M+H]+ peak. If the expected mass for a peptide like Semaglutide is 4113.6 Da, the observed mass should be within 0.01 Da. SaiyanMed also provides a “purity guarantee” on its product pages, stating that if a batch tests below 98% purity, they will replace it or issue a refund. However, this rarely happens because the internal quality gates catch most issues before the batch reaches Janoshik. The company also encourages researchers to submit their own samples for independent testing, and if the results differ, SaiyanMed will cover the cost of a retest at Janoshik. This open-book approach builds trust because you’re not relying on a single point of data. You can also cross-reference batch numbers across different products to see if a particular raw material batch was used in multiple peptides, which gives you insight into supply chain consistency. For instance, if you order BPC-157 and TB-500 from the same order, and both show similar impurity profiles, it might indicate a common raw material source. SaiyanMed’s support team can provide raw material CoAs upon request, though these are not published by default to protect supplier confidentiality. This level of data granularity is what separates a supplier from a research partner.
Logistics and Storage: Keeping Purity Intact After Testing
Even the purest peptide will degrade if stored or shipped improperly. SaiyanMed’s US-based warehouse is a key part of its purity chain. The facility is maintained at 2-8°C for peptides that require refrigeration, and at -20°C for long-term storage of lyophilized powders. Temperature is monitored continuously with data loggers that record readings every 15 minutes, and alarms trigger if the temperature deviates by more than 2°C. For shipping, SaiyanMed uses insulated boxes with gel ice packs (phase-change materials that stay at 0°C for 48 hours) for refrigerated items, and foam inserts for ambient-stable peptides. Orders are routed automatically based on the destination: US orders ship from the US warehouse, while international orders may go from the China warehouse. This reduces transit time and temperature exposure. The company also uses a “ship on Monday” policy for refrigerated items to avoid weekend delays. Each package includes a temperature indicator strip that changes color if the internal temperature exceeds 8°C for more than 4 hours. If the strip shows a breach, SaiyanMed will replace the order. This attention to logistics means that the purity verified by Janoshik is the purity you receive. The company also provides storage guidelines on the product label and on its website, including recommended reconstitution buffers (e.g., bacteriostatic water for most peptides) and shelf life after reconstitution (typically 7-14 days at 2-8°C). For researchers who need to store peptides for extended periods, SaiyanMed recommends keeping lyophilized powder at -20°C and avoiding repeated freeze-thaw cycles. The company is also developing a cold-chain shipping option for extremely heat-sensitive peptides, though this is not yet available for all products. By controlling the entire chain—from raw material to lyophilization to testing to shipping—SaiyanMed minimizes the variables that can compromise purity.